1.
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
by Schwartz, Sherwyn
Current medical research and opinion, 2011-01, Vol.27 (1), p.151-162

2.
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain
by Daniels, Stephen E
Current medical research and opinion, 2009-03, Vol.25 (3), p.765-776

3.
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A...
by Hartrick, Craig, MD
Clinical therapeutics, 2009, Vol.31 (2), p.260-271

4.
Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extens...
by Buynak, Robert, MD
Clinical therapeutics, 2015, Vol.37 (11), p.2420-2438

5.
Effects of Consumption of Pomegranate Juice on Carotid Intima–Media Thickness in Men and Women at Moderate Risk for Coronary Heart Disease
by Davidson, Michael H., MD
The American journal of cardiology, 2009, Vol.104 (7), p.936-942

6.
Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment
by Butler, Stephen F.
Pain medicine (Malden, Mass.), 2015-01, Vol.16 (1), p.119-130

7.
Tapentadol in cancer pain management: a prospective open-label study
by Mercadante, Sebastiano
Current medical research and opinion, 2012-11, Vol.28 (11), p.1775-1779

8.
Efficacy and Safety of Long-Term Administration of Tapentadol in Relieving Chronic Pancreatitis Pain
by Iacobellis, Angelo
Pain medicine (Malden, Mass.), 2017-04-01, Vol.18 (4), p.815-817

9.
Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients
by VISIOLI, Francesco
European journal of nutrition, 2005, Vol.44 (2), p.121-127

10.
A Combination of (ω–3) Polyunsaturated Fatty Acids, Polyphenols and L-Carnitine Reduces the Plasma Lipid Levels and Increases the Expression of Genes Involved in Fatty Acid Oxidati...
by Radler, Ulla
Annals of nutrition and metabolism, 2011-01-01, Vol.58 (2), p.133-140

11.
Acute postoperative pain relief with immediate-release tapentadol: randomized, double-blind, placebo-controlled study conducted in South Korea
by Lee, Y. K
Current medical research and opinion, 2014-12, Vol.30 (12), p.2561-2570

12.
Effects of de-alcoholised wines with different polyphenol content on DNA oxidative damage, gene expression of peripheral lymphocytes, and haemorheology: an intervention study in po...
by Giovannelli, Lisa
European journal of nutrition, 2010-04-27, Vol.50 (1), p.19-29

13.
Tea chemicals confirmed as cancer-busting compounds
by Morris, Kelly
The lancet oncology, 2002, Vol.3 (5), p.262-262

14.
A new mode of percutaneous upper thoracic phenol sympathicolysis : Report of 50 cases
by WANG, Yeou-Chih
Neurosurgery, 2001, Vol.49 (3), p.628-636

15.
Is there evidence that botulinum toxin injections are more effective than phenol injections in relieving poststroke reflex activity during plantar flexion, thereby increasing ankle...
by Cormack, Jody
Physical therapy, 2004-01, Vol.84 (1), p.76-84

16.
Intrathecal neurolytic blocks for the relief of cancer pain
by Candido, Kenneth
Best practice & research. Clinical anaesthesiology, 2003, Vol.17 (3), p.407-428

17.
Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study
by Hoyer, Carolin
European archives of psychiatry and clinical neuroscience, 2013-07-09, Vol.264 (3), p.255-261

18.
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim result...
by Sequist, Lecia V
The lancet oncology, 2020-03, Vol.21 (3), p.373-386

19.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
by Zajicek, John
The Lancet (British edition), 2003-11-08, Vol.362 (9395), p.1517-1526

20.
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation
by Park, S.J
Lung cancer (Amsterdam, Netherlands), 2012, Vol.77 (3), p.556-560
